Key metrics and charts across all fundamental categories.
Stock price and market valuation
HLNE trades at $81.4, a 45.2% decrease year-over-year. Market capitalization stands at $3.40B, down 43.6% from the prior year. Track HLNE price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$758.99M in TTM revenue grew 6.5% YoY, reaching $193.57M last quarter. TTM EBITDA of $334.82M on operating income of $82.25M shows growth is flowing through. Net income of $249.18M TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
With $2.30B in assets and $278.42M in long-term debt, the D/E of 0.3 shows a conservative capital structure — the company has a strong financial cushion to weather downturns.
Price multiples and return ratios
At 13.6x P/E, the stock trades below market averages — potentially undervalued. P/S of 4.5x and P/B of 3.7x provide additional context. Below-market P/E with growing revenue suggests a potential buying opportunity — the stock may be undervalued relative to its fundamentals.
Operating efficiency and return metrics
Op. margin of 42.5% is up 0.0% YoY — cost efficiency is improving. Net margin at 34.2%. ROE of 27.2% shows the company generates solid returns on shareholder equity.
Free cash flow, earnings quality, and capital allocation
FCF of $101.23M on $102.97M in operating cash flow. The FCF / Net Income ratio of 0.4x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $371.90M provide financial flexibility. Shares outstanding rose 2.9% YoY — shareholder dilution is eroding per-share value.
